Serum galectin-3 and fibroblast growth factor-23 levels in relation with type 2 diabetes and cardiovascular risk

Serum galectin-3 and fibroblast growth factor-23 levels in relation with type 2 diabetes and cardiovascular risk

Background: The clinical utility of galectin-3 and fibroblast growth factor 23 (FGF-23) needs to be further explored since previous studies show divergent results in relation to type 2 diabetes (T2D) and cardiovascular risk. Hence, the aim of this research was to explore galectin-3 and FGF-23 in rel...

Full description

Saved in:
Bibliographic Details
Main Authors: Klisic Aleksandra, Gluscevic Sanja, Karakasis Paschalis, Kotur-Stevuljevic Jelena, Ninic Ana
Format: Article
Language:English
Published: Society of Medical Biochemists of Serbia, Belgrade 2025-01-01
Series:Journal of Medical Biochemistry
Subjects:
diabetes
inflammation
insulin resistance
biomarkers
Online Access:https://scindeks-clanci.ceon.rs/data/pdf/1452-8258/2025/1452-82582501085K.pdf
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items